Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidProcare Pharmacy, L.L.C.
    Ask Trek AI about this page

    Procare Pharmacy, L.L.C. — Billing Profile & Reimbursement Data

    NPI 1518039858 · Honolulu, HI · Specialty Pharmacy

    Customize your policy alerts

    Sign up for Procare Pharmacy, L.L.C. — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Procare Pharmacy, L.L.C. is a specialty pharmacy provider located in Honolulu, Hawaii. This profile covers 0 Medicare and 8 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 8

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeOrganization
    OrganizationProcare Pharmacy, L.L.C.
    Address3375 Koapaka St Ste D105
    CityHonolulu
    StateHI
    ZIP96819
    TaxonomySpecialty Pharmacy
    NPI EnumeratedNovember 14, 2006

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicaid$41.8M
    Medicare$0

    Key Findings

    PROCARE PHARMACY, L.L.C. is effectively a Medicaid-focused specialty pharmacy in Honolulu: it reports $41.8M in total Medicaid revenue and has no Medicare billing on file, making Medicaid the sole payer of record in the dataset. The provider’s NPI was enumerated on 2006-11-14 (~20 years ago), indicating a long tenure in the market that aligns with an established specialty operation.

    Revenue is highly concentrated: the precomputed top-3 Medicaid codes account for 92.9% of this provider's total Medicaid revenue. The single largest driver is J3590 (Unclassified biologics) at $27.4M (65.5% of Medicaid revenue), followed by J3490 (Unclassified drugs) at $8.6M (20.6%) and J7307 (Etonogestrel implant system, including implant and supplies) at $2.9M (6.8%).

    The code mix and per-claim payments point to high-cost medication dispensing and device services consistent with a specialty pharmacy model. J3590 carries a $4402 avg paid/claim and J3490 a $2112 avg paid/claim, showing that large-dollar biologics and unclassified drugs drive most revenue, while J7307 ($931 avg paid/claim) indicates bundled device-and-supply billing for contraceptive implants.

    Competitive standing within the state is mixed by code. PROCARE ranks #1 of 4 providers for J3590 (100th percentile) and #1 of 2 providers for J7307 (100th percentile), signaling in-state dominance for those specific lines; by contrast J3490 ranks #13 of 49 providers (75th percentile), which indicates a solid but not market-leading position among peers for broadly categorized unclassified drugs.

    Several other Medicaid codes contribute materially but at much smaller scale, providing secondary revenue diversity. J7298 (Levonorgestrel-releasing IUD, 52 mg) adds $2.2M (5.3% of Medicaid revenue) and is listed as #1 of 1 providers with no state peer volume comparison available; J0585 (onabotulinumtoxina injection) contributes $590.4K (1.4%) and ranks #2 of 8 providers (86th percentile), indicating modest participation in botulinum toxin services.

    The dataset’s qualitative labels convey that volume for the two largest codes is described as typical rather than anomalous: J3590 is characterized as "typical, unremarkable volume for this code" despite its dominant share and top rank, and J3490 is similarly labeled "typical, unremarkable volume for this code" at the 75th percentile. Where peer comparisons are unavailable, such as J7298 (0th percentile; no state peer volume comparison available), the ranking should be interpreted as absence of comparable state data rather than a measured outlier.

    Given that the top three codes (J3590, J3490, J7307) together represent 92.9% of Medicaid revenue, this provider’s financial performance is highly sensitive to utilization and reimbursement changes for a very small set of high-cost products. Analysts should view revenue volatility risk as concentrated in unclassified biologics/drugs and contraceptive device lines rather than a broad portfolio of services.

    From a payer or network-management perspective, PROCARE’s profile signals a specialized supplier role: it handles high-cost biologics and contraceptive implants with long-tenured billing history and strong in-state positioning on specific codes, but limited payer diversification because there is no Medicare activity on file. Contracting, utilization management, or formulary actions affecting J3590 or J3490 would likely have outsized impact on the provider’s Medicaid revenue stream.

    Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

    Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.

    View: By Year1 / 3

    Medicaid: Complete Services Breakdown

    Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

    8 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J3590Unclassified biologics6,220$4,400$27.4M
    J3490Unclassified drugs4,080$2,110$8.6M
    J7307Etonogestrel (contraceptive) implant system, including implant and supplies3,060$930$2.9M
    J7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg2,320$960$2.2M
    J0585Injection, onabotulinumtoxina, 1 unit590$1,000$590.4K
    90782N/A40$2,700$102.7K
    J7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg50$880$39.7K
    J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)40$600$24.7K

    Medicaid: Competitive Analysis & Benchmarks

    How this provider's Medicaid billing volume and revenue compare to other Hawaii providers billing the same CPT/HCPCS codes.

    Full comparison — all codes billed, vs. Hawaii median

    8 rows

    CPT/HCPCS CodeDescriptionRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J3590Unclassified biologics110690$4,180$8M
    J7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg1102,320$960$2.2M
    J7307Etonogestrel (contraceptive) implant system, including implant and supplies1101,570$930$1.5M
    J3490Unclassified drugs1350160$200$740.3K
    J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)210750$700$525.5K
    J0585Injection, onabotulinumtoxina, 1 unit21050$1,110$350.9K
    90782N/A31070$1,190$76.1K
    J7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg11050$880$39.7K

    Nearby Providers

    Other providers in the same ZIP code as Procare Pharmacy, L.L.C., ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Kaiser Foundation HospitalsHIGeneral Acute Care Hospital$0$76.5M
    Hawaii Permanente Medical Group IncHIHealth Maintenance Organization$0$75.8M
    Value Drug LtdHIPharmacy$0$21.7M
    Care Hawaii, Inc.HICommunity/Behavioral Health Agency$0$11.8M
    Kokua Kalihi Valley Comprehensive Family ServicesHIFederally Qualified Health Center (FQHC)$0$10M
    Hawaii Life Flight, LLCHIAir Ambulance$636.1K$8.5M
    City And County Of HonoluluHILand Ambulance$3.3M$5.3M
    Keiki Dental SpecialistsHIPediatric Dentistry$0$5.7M
    Kokua Kalihi Valley Comprehensive Family ServicesHIFederally Qualified Health Center (FQHC)$0$2M
    Imua Medical Equipment And Supplies,llcHIDurable Medical Equipment & Medical Supplies$0$1.7M

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicaid Revenue by Year vs. Hawaii Providers
    7 of 7 years billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Claims Volume vs. Hawaii Distribution
    Procare Pharmacy, L.L.C. — 2 of 8 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Hawaii